Drug Topics

JANUARY 22, 2025

The US government is entrusting mRNA vaccine pioneers Moderna to develop protection for the gradually increasing threat of avian influenza.

Vaccines 464

Vaccines 464

The Checkup by Singlecare

JANUARY 22, 2025

Propranolol is widely prescribed to treat heart conditions such as high blood pressure, arrhythmias, angina (chest pain), or a combination of these conditions. It belongs to a class of drugs known as beta-adrenergic receptor antagonists, more commonly called beta blockers. Understanding this medications duration of action can help you better manage symptoms and avoid potential side effects from missed doses.

Labelling 98

Labelling Hospitals FDA 98

Drug Topics

JANUARY 22, 2025

Erin Fox, PharmD, MHA, BCPS, FASHP, discussed the 2025 Pharmacy Forecast and its perspective on managing ultra-high-cost drugs.

247

247

Pharmacy Times

JANUARY 22, 2025

The FDA approved treosulfan, in combination with fludarabine, for patients 1 year of age and older with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).

FDA 148

FDA 148

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

PharmaVoice

JANUARY 22, 2025

The company is kicking off the year with a new Novartis partnership and renewed focus on metabolic aging targets.

147

147

Fierce Healthcare

JANUARY 22, 2025

In 2022, negotiated commercial prices for evaluation and management office visits were 11% higher for hospital-affiliated PCPs and 8% higher for private equity-affiliated PCPs, as compared to those at independent practices.

Hospitals 134

Hospitals 134

Fierce Healthcare

JANUARY 22, 2025

The feds intend to appeal a judge's decision that would force them to recalculate UnitedHealthcare's Medicare Advantage star ratings. | The feds intend to appeal a judge's decision that would force them to recalculate UnitedHealthcare's Medicare Advantage star ratings.

128

128

Pharmacy Times

JANUARY 22, 2025

Vusolimogene oderparepvec in combination with nivolumab is being assessed to treat individuals with unresectable or metastatic stage IIIb-IV cutaneous melanoma.

FDA 123

FDA 123

Med Ed 101

JANUARY 22, 2025

Do you ever get those questions where you know you are correct but you have to check the literature? I believe I’ve come across this order once or twice in my career: oral lorazepam PRN for a seizure. Can this be done? Here are the details on why this shouldn’t be done. Can I give […] The post Oral Lorazepam PRN For A Seizure? Is This Right?

52

52

pharmaphorum

JANUARY 22, 2025

The UK government has launched a 150 million procurement drive for artificial intelligence tools that can be used by the NHS.

110

110

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

PhRMA

JANUARY 22, 2025

Making the best decision about which medicines to take should be a decision between patients and their doctors, not unelected bureaucrats. Price-setting boards, such as the prescription drug affordability board (PDAB) being proposed in Virginia, ignore this principle and threaten access to life-saving medicines.

100

100

pharmaphorum

JANUARY 22, 2025

A UK alliance between data scientists, clinical researchers, and community opticians hopes to develop an AI to predict dementia during an eye test.

97

97

Fierce Healthcare

JANUARY 22, 2025

Primary care and women's health company Tia has big plans for 2025 as it aims to open more locations and partner with new health systems. | Primary care and women's health company Tia has big plans for 2025 as it aims to open more locations and partner with new health systems.

88

88

The Happy PharmD

JANUARY 22, 2025

More and more pharmacists are walking away from the profession. The white coat is coming off, and pharmacists are heading for the exit. Its a mass exodus that’s just beginning, and its happening for a lot of reasons, each one contributing to a situation thats not just bad for the pharmacy industry but for healthcare as a whole If youre in pharmacy or know someone who is, youve probably noticed the increasing stress and dissatisfaction in the profession.

Patient Care 85

Patient Care Hospitals 85

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JANUARY 22, 2025

Pharmacists ensure responsible antibiotic use, combating resistance through tailored therapies.

81

81

pharmaphorum

JANUARY 22, 2025

Johnson & Johnson's Spravato has become the first standalone drug to be cleared by the FDA for adults with treatment-resistant depression

FDA 75

FDA 75

Pharmacy Times

JANUARY 22, 2025

A panel of experts discuss treatment of HR+, HER2 breast cancer with therapies such as ribociclib, alpelisib, everolimus, and elacestrant.

73

73

Fierce Healthcare

JANUARY 22, 2025

Moodys, S&P and Fitch collectively issued 95 credit downgrades and 37 upgrades to nonprofit hospitals in 2024, a trend likely to continue in 2025, according to Kaufman Hall.

Hospitals 71

Hospitals 71

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JANUARY 22, 2025

Engaging with the community, providing transparent information to patients, and using noncoercive methods of encouragement are strategies to reduce COVID-19 vaccine hesitancy.

Vaccines 73

Vaccines 73

Fierce Healthcare

JANUARY 22, 2025

Jay Chaudary, former director of the Indiana Division of Mental Health and Addiction, led the effort to overhaul the state's behavioral health system. He takes listeners through lessons learned and potential future policy threats to care access.

71

71

Pharmacy Times

JANUARY 22, 2025

Many treatments are off-label, so pharmacists can educate clinicians and help patients with access.

Labelling 73

Labelling 73

Pharma Times

JANUARY 22, 2025

Europes first biomarker trial seeks to prevent Crohns Disease onset

69

69

Pharmacy Times

JANUARY 22, 2025

Panelists discuss how the safety profiles of second-line primary biliary cholangitis (PBC) therapies in compensated cirrhosis show varying levels of risk, with recent abstracts from EASL and AASLD 2024.

65

65

pharmaphorum

JANUARY 22, 2025

Discover the key trends and innovations shaping the pharma and life sciences industries in 2025, focusing on efficiency, patient care, customer experience, and advancements in rare disease treatments.

Patient Care 64

Patient Care 64

Pharmacy Times

JANUARY 22, 2025

Panelists discuss how long-term safety monitoring for second-line primary biliary cholangitis (PBC) therapies requires systematic assessment of liver function, lipid profiles, and potential drug-specific adverse effects while emerging 5-year safety data for seladelpar continues to demonstrate a favorable risk profile compared with other treatment options.

65

65

Pharmaceutical Commerce

JANUARY 22, 2025

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Donald Prentiss, founder and CEO, Qualthera, describes the importance of the patient within the pharma supply chain.

64

64

Pharmacy Times

JANUARY 22, 2025

Pharmacists play a significant role in managing gout by educating patients about the disease and ensuring proper medication adherence to urate-lowering therapy.

65

65

Pharmaceutical Technology

JANUARY 22, 2025

The FDAs decision marks J&J's Spravato as the first monotherapy for adults with treatment-resistant depression.

Labelling 64

Labelling FDA 64

Pharmacy Times

JANUARY 22, 2025

The study shows benefits when Hecolin (HEV 239; Xiamen Innovax Biotech Co Ltd) is administered in 2 doses, rather than the typical 3-dose regimen.

Vaccines 65

Vaccines 65

Pharmaceutical Technology

JANUARY 22, 2025

Glox Therapeutics is set to receive a share of the 3m ($3.67m) Collaborative Discovery Programme (CDP) funding.

59

59

Pharmacy Times

JANUARY 22, 2025

A phase 2 trial investigates MRD detection and therapy advancements.

65

65

Pharmaceutical Technology

JANUARY 22, 2025

Tagrisso and Imfinzi are projected to generate global sales of $8bn and $7bn, respectively, by 2030, according to GlobalData.

59

59

Pharmacy Times

JANUARY 22, 2025

Black and Native American patients were about 2 to 3 times more likely to die of cancer compared with White patients, and women younger than 50 years were affected more than male patients.

62

62